SCHEMBL933505

SCHEMBL933505

Nc1cccc([C@]23COC[C@@H]2CN=C(NC(=O)c2ccccc2)S3)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HDAC2 Q92769 4/20 0.36
HDAC1 Q13547 4/20 0.36
HDAC3 O15379 4/20 0.36
NCOR1 O75376 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
BACE1 P56817 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
KDM4E B2RXH2 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
HCRTR1 O43613 2/20 0.33
HCRTR2 O43614 1/20 0.33
ADCY1 Q08828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL933518 0.84 HDAC1 (0.39) CYP1A2MAPTCYP2C9CYP2C19HDAC2
SCHEMBL16056122 0.83 HDAC1 (0.34) CYP1A2MAPTCYP2C9CYP2C19HDAC2
SCHEMBL16055734 0.81 HDAC1 (0.33) CYP1A2MAPTCYP2C9CYP2C19HDAC2
SCHEMBL933387 0.80 USP2 (0.34) HSD17B10
SCHEMBL966675 0.77 BACE1 (0.49) CYP1A2MAPTCYP2C9CYP2C19HDAC1
SCHEMBL18192811 0.77 BACE1 (0.49) CYP1A2MAPTCYP2C9CYP2C19HDAC1
SCHEMBL933016 0.77 BACE1 (0.45) MAPTHDAC1HDAC8BACE1NPC1
SCHEMBL16057539 0.76 BACE1 (0.45) HDAC2HDAC1HDAC3HDAC8BACE1
SCHEMBL932814 0.75 BACE1 (0.46) HDAC3BACE1NCOR2
SCHEMBL933126 0.72 KCNH2 (0.35) MAPTHDAC1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451793-A1 BACE INHIBITORS Eli Lilly and Company (US) 2012-05-16 EP disclosed
WO-2011005738-A1 BACE INHIBITORS ELI LILLY AND COMPANY (US) 2011-01-13 WO disclosed